Literature DB >> 12771600

Cytochrome P450 3A4 activity after surgical stress.

Curtis E Haas1, David C Kaufman, Carolyn E Jones, Aaron H Burstein, William Reiss.   

Abstract

OBJECTIVE: To evaluate the relationship between the acute inflammatory response after surgical trauma and changes in hepatic cytochrome P450 3A4 activity, compare changes in cytochrome P450 3A4 activity after procedures with varying degrees of surgical stress, and to explore the time course of any potential drug-cytokine interaction after surgery.
DESIGN: Prospective, open-label study with each patient serving as his or her own control.
SETTING: University-affiliated, acute care, general hospital. PATIENTS: A total of 16 patients scheduled for elective repair of an abdominal aortic aneurysm (n = 5), complete or partial colectomy (n = 6), or peripheral vascular surgery with graft (n = 5).
INTERVENTIONS: Cytochrome P450 3A4 activity was estimated using the carbon-14 [14C]erythromycin breath test (ERMBT) before surgery and 24, 48, and 72 hrs after surgery. Abdominal aortic aneurysm and colectomy patients also had an ERMBT performed at discharge. Blood samples were obtained before surgery, immediately after surgery, and 6, 24, 32, 48, and 72 hrs after surgery for determination of plasma concentrations of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha. Clinical markers of surgical stress that were collected included duration of surgery, estimated blood loss, and volume of fluids administered in the operating room.
MEASUREMENTS AND MAIN RESULTS: ERMBT results significantly declined in all three surgical groups, with the lowest value at the time of the 72-hr study in all three groups. There was a trend toward differences in ERMBT results among groups that did not reach statistical significance (p =.06). The nadir ERMBT result was significantly and negatively correlated with both peak interleukin-6 concentration (r(s) = -.541, p =.03) and log interleukin-6 area under the curve from 0 to 72 hrs (r(s) = -.597, p =.014). Subjects with a peak interleukin-6 of >100 pg/mL had a significantly lower nadir ERMBT compared with subjects with a peak interleukin-6 of <100 pg/mL (35.5% +/- 5.2% vs. 74.7% +/- 5.1%, p <.001).
CONCLUSIONS: Acute inflammation after elective surgery was associated with a significant decline in cytochrome P450 3A4 activity, which is predictive of clinically important changes in the metabolism of commonly used drugs that are substrates for this enzyme.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771600     DOI: 10.1097/01.CCM.0000063040.24541.49

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  15 in total

1.  Therapeutic protein drug-drug interactions: navigating the knowledge gaps-highlights from the 2012 AAPS NBC Roundtable and IQ Consortium/FDA workshop.

Authors:  Jane R Kenny; Maggie M Liu; Andrew T Chow; Justin C Earp; Raymond Evers; J Greg Slatter; Diane D Wang; Lei Zhang; Honghui Zhou
Journal:  AAPS J       Date:  2013-06-21       Impact factor: 4.009

2.  Sources of Interindividual Variability.

Authors:  Yvonne S Lin; Kenneth E Thummel; Brice D Thompson; Rheem A Totah; Christi W Cho
Journal:  Methods Mol Biol       Date:  2021

3.  The utility of a system dynamics approach for understanding cumulative health risk from exposure to environmental hazards.

Authors:  John D Prochaska; Hyunjung Kim; Robert N Buschmann; Daniel Jupiter; Sharon Croisant; Stephen H Linder; Ken Sexton
Journal:  Environ Res       Date:  2019-02-27       Impact factor: 6.498

4.  Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period.

Authors:  Xiaoqing Zhang; Zhaowen Wang; Junwei Fan; Gaolin Liu; Zhihai Peng
Journal:  Eur J Clin Pharmacol       Date:  2011-02-26       Impact factor: 2.953

5.  Development of a Physiologically Based Pharmacokinetic Model to Predict Disease-Mediated Therapeutic Protein-Drug Interactions: Modulation of Multiple Cytochrome P450 Enzymes by Interleukin-6.

Authors:  Xiling Jiang; Yanli Zhuang; Zhenhua Xu; Weirong Wang; Honghui Zhou
Journal:  AAPS J       Date:  2016-03-09       Impact factor: 4.009

6.  [Perioperative patient management. Evaluation of subjective stress and demands of patients undergoing elective gynaecological surgery].

Authors:  B Gauter-Fleckenstein; R Kaviani; C Weiss; A Burges; M Korell; C Anthuber; H-D Hermann; E Weninger; U Kreimeier
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

Review 7.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

8.  Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients.

Authors:  Géraldine Pettersen; Mohamad-Samer Mouksassi; Yves Théorêt; Line Labbé; Christophe Faure; Bao Nguyen; Catherine Litalien
Journal:  Br J Clin Pharmacol       Date:  2008-10-23       Impact factor: 4.335

9.  Variability in drug metabolizing enzyme activity in HIV-infected patients.

Authors:  Amanda E Jones; Kevin C Brown; Rebecca E Werner; Karl Gotzkowsky; Andrea Gaedigk; Mike Blake; David W Hein; Charles van der Horst; Angela D M Kashuba
Journal:  Eur J Clin Pharmacol       Date:  2010-01-19       Impact factor: 2.953

Review 10.  [Opioids during anesthesia in liver and renal failure].

Authors:  C Höhne; B Donaubauer; U Kaisers
Journal:  Anaesthesist       Date:  2004-03       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.